Spark Investment Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,700
Closed -$23K 592
2019
Q4
$23K Buy
+3,700
New +$27.2K ﹤0.01% 533
2018
Q2
Sell
-16,430
Closed -$476K 777
2018
Q1
$476K Sell
16,430
-10,390
-39% -$304K 0.03% 406
2017
Q4
$748K Sell
26,820
-12,580
-32% -$391K 0.04% 400
2017
Q3
$1.44M Buy
+39,400
New +$1.22M 0.08% 327
2017
Q1
Sell
-9,580
Closed -$51K 938
2016
Q4
$51K Sell
9,580
-13,686
-59% -$91.2K ﹤0.01% 742
2016
Q3
$207K Sell
23,266
-6,014
-21% -$56.6K 0.02% 664
2016
Q2
$281K Buy
+29,280
New +$282K 0.03% 565
2016
Q1
Sell
-12,760
Closed -$160K 884
2015
Q4
$160K Buy
+12,760
New +$152K 0.02% 612
2015
Q3
Sell
-12,140
Closed -$211K 796
2015
Q2
$211K Sell
12,140
-21,270
-64% -$383K 0.03% 512
2015
Q1
$481K Buy
33,410
+14,670
+78% +$160K 0.07% 381
2014
Q4
$156K Buy
18,740
+6,240
+50% +$57.1K 0.03% 527
2014
Q3
$140K Buy
12,500
+8,510
+213% +$108K 0.02% 557
2014
Q2
$72K Buy
+3,990
New +$51.9K 0.01% 582
2014
Q1
Sell
-2,390
Closed -$43K 772
2013
Q4
$43K Buy
+2,390
New +$47.9K 0.01% 615

Other funds holding AVEO

Spark Investment Management's AVEO Position: Q1 2020 in Review

Spark Investment Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2020, closing a stake of 3,700 shares — an estimated $23K sold.

Spark Investment Management first reported a position in AVEO in Q4 2013 and held it in 14 quarters. The position peaked at $1.44M in Q3 2017. 35 funds tracked by Wall St. Rank hold AVEO as of Q1 2020.

  • Spark Investment Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Spark Investment Management sold 3,700 AVEO Pharmaceuticals, Inc. shares in Q1 2020, an estimated $23K.
  • Spark Investment Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2013 and held it in 14 quarters.
  • Spark Investment Management's AVEO Pharmaceuticals, Inc. position peaked at $1.44M in Q3 2017.
  • 35 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2020.

Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.